Douglas J. Seith

This profile gathers the share dealings of Douglas J. Seith in AtriCure, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 31 December 2015 to 30 June 2026, the count stands at 15 filings.

Sales make up the whole of the open-market record (2 sales, €1.9M). Other entries cover 13 share grants.

Most recently, on 2 July 2026, the filings show a share grant in AtriCure, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.